Researchers from the Eugin Group have developed EXPECTmore, an algorithm that accurately predicts the chances of pregnancy in assisted reproduction.

A pioneering algorithm based on artificial intelligence accurately predicts the chances of pregnancy in women undergoing assisted reproduction procedures. EXPECTmore, which was developed in Spain by researchers from the data team of the Eugin group’s assisted reproduction and fertility centres, uses data from over 200,000 patients attending our clinics.

Until now, pregnancy predictions in assisted reproduction treatments have been based on the past results of previous patients, according to age ranges. “However, it is obvious that, even if two patients are the same age, they will not have the same chances of success, as there are many other factors that have an influence,” says Dr Rita Vassena, the Eugin Group’s Scientific Director. She adds that “this is where our model comes in, as it takes into account fundamental factors other than just age in order to adjust those expected pregnancy probabilities for each patient”.

To do this, it uses artificial intelligence, which allows it to gather a significant amount of data to which powerful algorithms are applied, enabling it to identify relationships between a multitude of factors and the results of the treatments. “The result is a novel and highly scientific method of prediction, which takes into account dozens of elements analysed by using data from more than 200,000 patients who have been treated in our clinics, in order to arrive at a fully personalised prediction adapted to the specific case of each woman,” explains Vassena.

The model also enables us to know the results that a patient who uses her partner’s gametes would obtain, as well as if she decided to undergo treatment with donor gametes. In addition, it can make recommendations to each patient on actions or habits to optimise the success of the treatment. “Beyond the valuable information we obtain from the prediction, we also address couples’ concerns about having a participatory role in their treatment. For the first time, our algorithms identify which aspects patients themselves can influence and thus approach treatment in an active and shared way,” continues Vassena.

“The goal is to bring clarity and to be honest with patients so that they can decide, together with their doctor, what the best way forward is. And now we are in a position to provide individualised and specific information to make those decisions even more informed and enlightened,” concludes Vassena.

The EXPECTmore tool is available during the first visit at Eugin via the specialist doctor, who will always provide the patient with all the information.

It can be requested by calling +34 933 221 122 for Eugin Barcelona, 913 360 400 for Eugin Madrid or by scheduling it yourself through the website.

There is no doubt that at Eugin we see research as a key factor in everything we do. As part of this great endeavour, carried out on a daily basis by our research team, and thanks to valuable breakthroughs such as EXPECTmore, we are proud to continue improving and making the latest scientific and technological developments in reproductive medicine available to our patients.